Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2641)
All Articles published online
|
Dec 15, 2004 (publication date) through Nov 9, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Xu HY, Yang YL, Liu SM, Bi L, Chen SX. Effect of arsenic trioxide on human hepatocarcinoma in nude mice. World J Gastroenterol 2004; 10(24): 3677-3679 [PMID: 15534931 DOI: 10.3748/wjg.v10.i24.3677] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i24/3677.htm |
| Number | Citing Articles |
| 1 |
Nak Jong Seong, Chang Jin Yoon, Sung-Gwon Kang, Jin Wook Chung, Hyo-Cheol Kim, Jae Hyung Park. Effects of Arsenic Trioxide on Radiofrequency Ablation of VX2 Liver Tumor: Intraarterial versus Intravenous Administration. Korean Journal of Radiology 2012; 13(2): 195 doi: 10.3348/kjr.2012.13.2.195
|
| 2 |
Lifeng Qi, Zirong Xu, Minli Chen. In vitro and in vivo suppression of hepatocellular carcinoma growth by chitosan nanoparticles. European Journal of Cancer 2007; 43(1): 184 doi: 10.1016/j.ejca.2006.08.029
|
| 3 |
Xin-Yu Zhang, Shu-Meng Yang, Hao-Peng Zhang, Yue Yang, Shi-Bo Sun, Jian-Ping Chang, Xuan-Chen Tao, Tuo-Yun Yang, Chun Liu, Yan-Mei Yang. Endoplasmic reticulum stress mediates the arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells. The International Journal of Biochemistry & Cell Biology 2015; 68: 158 doi: 10.1016/j.biocel.2015.09.009
|
| 4 |
Akiko Kojima-Yuasa, Xuedan Huang, Isao Matsui-Yuasa. Synergistic Anticancer Activities of Natural Substances in Human Hepatocellular Carcinoma. Diseases 2015; 3(4): 260 doi: 10.3390/diseases3040260
|
| 5 |
Lei Wang, Ren Wang, Lin Fan, Wentao Liang, Kai Liang, Yingxin Xu, Guizhu Peng, Qifa Ye. Arsenic trioxide is an immune adjuvant in liver cancer treatment. Molecular Immunology 2017; 81: 118 doi: 10.1016/j.molimm.2016.12.001
|
| 6 |
Hui Yu, Guang-Yu Zhu, Rui-Zhi Xu, Huan-Zhang Niu, Qin Lu, Guo-Zhao Li, Zi-Yu Wang, Dong-Sheng Zhang, Ning Gu, Gao-Jun Teng, Martin Brechbiel. Arterial Embolization Hyperthermia Using As2O3 Nanoparticles in VX2 Carcinoma–Induced Liver Tumors. PLoS ONE 2011; 6(3): e17926 doi: 10.1371/journal.pone.0017926
|
| 7 |
Ramon C Sun, Philip G Board, Anneke C Blackburn. Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells. Molecular Cancer 2011; 10(1) doi: 10.1186/1476-4598-10-142
|
| 8 |
Sanjay Kumar, Pratibha Kumari, Rajeev Singh. Nanoparticles in Medicine. 2020; : 25 doi: 10.1007/978-981-13-8954-2_2
|
| 9 |
Judy Yuet-Wa Chan, Katy Pak-Yan Siu, Kwok-Pui Fung. Effect of arsenic trioxide on multidrug resistant hepatocellular carcinoma cells. Cancer Letters 2006; 236(2): 250 doi: 10.1016/j.canlet.2005.05.017
|
| 10 |
Hye Jin Kim, Ji Hoon Shin, Tae-Hyung Kim, Eun Young Kim, Young Soo Park, Chan-Sik Park, Ho-Young Song. Efficacy of Transarterial Embolization with Arsenic Trioxide Oil Emulsion in a Rabbit VX2 Liver Tumor Model. Journal of Vascular and Interventional Radiology 2009; 20(10): 1365 doi: 10.1016/j.jvir.2009.07.005
|
| 11 |
Lei Wang, Xiang Hu, Yingxin Xu, Zhong Liu. Arsenic trioxide inhibits lung metastasis of mouse colon cancer via reducing the infiltration of regulatory T cells. Tumor Biology 2016; 37(11): 15165 doi: 10.1007/s13277-016-5377-3
|
| 12 |
Jonathan D. Schwartz, Josep M. Llovet. Molecular Targeting in Oncology. Cancer Drug Discovery and Development 2008; : 165 doi: 10.1007/978-1-59745-337-0_8
|
| 13 |
Jennifer Wu, Charles Henderson, Lynn Feun, Peter Van Veldhuizen, Philip Gold, Hui Zheng, Theresa Ryan, Lawrence S. Blaszkowsky, HaoBin Chen, Max Costa, Barry Rosenzweig, MaryLynn Nierodzik, Howard Hochster, Franco Muggia, Giovanni Abbadessa, Jonathan Lewis, Andrew X. Zhu. Phase II study of darinaparsin in patients with advanced hepatocellular carcinoma. Investigational New Drugs 2010; 28(5): 670 doi: 10.1007/s10637-009-9286-9
|
| 14 |
Hongchi Jiang, Yong Ma, Xiaoning Chen, Shangha Pan, Bei Sun, Geoffrey W. Krissansen, Xueying Sun. Genistein synergizes with arsenic trioxide to suppress human hepatocellular carcinoma. Cancer Science 2010; 101(4): 975 doi: 10.1111/j.1349-7006.2009.01464.x
|
| 15 |
Bing Liu, Shangha Pan, Xuesong Dong, Haiquan Qiao, Hongchi Jiang, Geoffrey W. Krissansen, Xueying Sun. Opposing effects of arsenic trioxide on hepatocellular carcinomas in mice. Cancer Science 2006; 97(7): 675 doi: 10.1111/j.1349-7006.2006.00230.x
|
| 16 |
Hui Wang, Ying Liu, Xiu Wang, Donghui Liu, Zhiqiang Sun, Chun Wang, Gang Jin, Beiguang Zhang, Shilong Yu. Randomized clinical control study of locoregional therapy combined with arsenic trioxide for the treatment of hepatocellular carcinoma. Cancer 2015; 121(17): 2917 doi: 10.1002/cncr.29456
|